Team

A team that spans the whole distance, from the science to the boardroom.

Deep diagnostics science, IVD operations, commercial leadership and clinical insight, in one small, focused group.

Leadership

Sean Macfarlane

Founder & CEO

Sean founded Biomarx to make personalised medicine equitable — to take genomic diagnostics out of the specialist lab and into everyday care. A molecular diagnostics scientist by background, he spent years at Randox and in clinical laboratories before building Biomarx around a single conviction: that early, accurate cancer detection shouldn't depend on where you live or what you can pay. Biomarx was named an InterTradeIreland Seedcorn DeepTech regional winner (2025). Based in Belfast and Glasgow.

Prof. Damion Corrigan

Chief Scientific Officer

Damion is a leading authority in clinical electrochemical biosensing and an experienced academic founder — LGC Professor at the University of Strathclyde, and founder or scientific lead of multiple diagnostics ventures. He specialises in taking diagnostic technologies from early-stage research through to real-world deployment, at the interface of electrochemistry, assay development and device engineering. He is the scientific lead of Biomarx.

Alex Harkin

Chief Operating Officer

Alex brings the operational and regulatory backbone. A specialist in in-vitro diagnostics with years leading R&D at Randox, she has direct expertise in IVD product registration under the EU IVD-R framework and US FDA 510(k) clearance — exactly the disciplines that turn a strong technology into an approved, manufacturable product.

Oscar Weipers

Development Engineer

Oscar leads hands-on device and electronics development, bringing biomedical-engineering rigour (MEng, University of Strathclyde) to building the system that makes the science usable.

Board

Sara Roberts

Chair

Four-time founder and healthtech commercialisation specialist, and a recognised voice in preventative medicine. Sara brings commercial strategy and board-level governance as Biomarx moves from science to scale.

Matt Ward

Board Observer

Investment Manager, Clarendon Fund Managers.

Dr Catherine Breslin

Board Observer

Head of Industry Engagement & Commercialisation, University of Strathclyde.

Scientific & Advisory Board

Sarah Regan

Supply Chain & Manufacturing Advisor

Former OEM lead for major biotech firms, with experience managing portfolios upwards of £100m ARR, guiding the path from prototype to manufactured product at scale.

Colin Bayne

Scientific Advisor

An experienced former Principal Scientist with almost 20 years’ experience in molecular primer design and validation.